Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

NCT04707391 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1250

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis, Meningococcal

Interventions

COMBINATION_PRODUCT: MenABCWY vaccine
COMBINATION_PRODUCT: Placebo
BIOLOGICAL: MenACWY vaccine
COMBINATION_PRODUCT: MenB vaccine

Sponsor

GlaxoSmithKline